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Rate-modulated pacing modes adjust the stimulus rate by 
responding to sensed alterations in physiologic indexes of 
metabolic demand. This study was designed to determine 
whether right ventricular pre-ejection interval, measured 
in patients by a prototype pacemaker system capable of 
tracking intraventricular volume, changes predictably with 
exercise and, if so, whether it can be used in an algorithm 
to vary heart rate appropriately. This system utilizes intra- 
ventricular electrical impedance measurements of injected 
microampere currents to determine intracavitary volume 
changes. 
Five pacemaker-dependent patients underwent tempo- 
rary insertion of a tripolar electrode connected to an 
external device that sensed cardiac signals, generated an 
impedance wave form and produced stimuli at rates depen- 
Patients who exhibit inappropriate bradycardia during exer- 
cise may be limited in their activities because of inadequate 
cardiac output. When bradycardia is not due to abnormal 
sinus node function, pacemaker rate modulation can be 
restored by P-synchronous (DDD) pacing. Individuals 
whose sinus node function is not suitable as an indicator of 
physiologic heart rate modulation, however, include those 
with atria1 fibrillation or other supraventricular tachyar- 
rhythmias associated with a slow ventricular response, atria1 
standstill. chronotropic incompetence of the sinus node 
and those in whom satisfactory atria1 sensing cannot be 
achieved. Pacemaker systems incorporating sensors of other 
physiologic variables that reflect the global metabolic de- 
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dent on pre-ejection interval. Pre-ejection interval did not 
change as a result of variations in pacing rate itself (347 2 
41 ms at 70 beatslmin versus 321 f 19 ms at 130 beats/mitt), 
but consistently decreased during graded exercise (by 23% 
from baseline). During rate-modulated pacing based on 
pre-ejection interval, heart rate significantly increased dur- 
ing exercise compared with ventricular demand pacing (by 
46 + 6 versus 7 f 6 beats/mitt, respectively), and increased 
appropriately during burst exercise. 
Thus, the pre-ejection interval appears to be a specific, 
reliable physiologic determinant of pacing rate during 
exertion, which may be applicable in implantable rate- 
modulated pacemakers. 
(J Am CON Cardiol1989;14:1753-8) 
mand of the patient and, thus, might be used as a determi- 
nant of pacing rate are currently in clinical use or under 
investigation. 
One such variable is the systolic pre-ejection interval, 
which is the measurable duration of time reflecting isovolu- 
mic contraction of the ventricle. It has long been recognized 
that the pre-ejection interval decreases in response to in- 
creased stroke volume or end-diastolic volume (I,?) or to 
augmented contractility caused by adrenergic influences 
during exercise (3-5). Conversely. heart rate itself has little 
direct effect on the duration of the pre-ejection interval (6), 
particularly within the physiologic range of heart rate varia- 
tion (1). This profile of the qualities of the pre-ejection 
interval potentially permits its application as a physiologic 
determinant of heart rate requirements in a rate-modulating 
pacing system. 
The development of a pacing system that is capable of 
monitoring intraventricular volume by measuring changes in 
the electrical impedance of the ventricular chamber has 
allowed testing of the hypothesis that determination of the 
pre-ejection interval can form the basis of a pacing system 
that modulates heart rate in response to the metabolic 
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Table 1. Clinical Features of Five Patients 
Patient Age W Pacemaker Other Medical Concurrent 
No. Gender Indication Diagnoses Medications 
I 62/M CHB Hypertension Maxzide, prazosin 
2 60/M CHB HCM (nonobstructive) Inderide 
3 68/M CHB Gout, esophageal Cobenemid 
reflux 
4 28/F Intermittent CHB None None 
5 62/M CHB Crohn’s disease Gelusil, Metamucil 
CHB = complete heart block; F = female; HCM = hypertrophic cardiomyopathy; M = male. 
demand imposed by exertion. This study examined the effect 
of exercise on the measured pre-ejection interval and paced 
heart rate when such a pacing system was utilized in five 
pacemaker-dependent patients. 
Methods 
Patient selection. Patients were selected for participation 
from the group of pacemaker-dependent patients who had 
previously undergone permanent pacemaker implantation 
and who were being followed up by the pacemaker division 
of the Mayo Clinic. Criteria for selection included 1) consis- 
tent pacemaker dependency during serial telephone monitor- 
ing, 2) absence of previous pacemaker complications, 
3) geographic proximity to Rochester, Minnesota, and 4) 
willingness to participate as evidenced by signing informed 
consent forms. Patients were excluded if there was 
1) clinical or laboratory evidence of ischemic heart disease, 
2) a history of significant exertion-related tachyarrhythmia 
or syncope, 3) inability to perform upright bicycle exercise 
because of orthopedic or other limitation, 4) clinically sig- 
nificant valvular disease, or 5) any contraindication to insert- 
ing a temporary pacing electrode into the right ventricle by 
means of subclavian or internal jugular venipuncture. Eight 
potential subjects who were willing to participate were 
identified. Two subjects, however, had normal sinus rhythm 
with appropriate pacemaker inhibition at the outset of the 
study. One subject was found to have previously unsus- 
pected superior vena cava obstruction at the time of at- 
tempted right ventricular pacemaker wire insertion. The 
remaining five patients (Table 1) completed the entire pro- 
cedure without complications. 
Patient recruitment and study methods were reviewed 
and approved by the Institututional Review Boards of the 
Mayo Clinic and Cardiac Pacemakers, Inc. 
Equipment. The investigational pacing apparatus con- 
sisted of a special tripolar pacing lead connected to an 
external pacing system. The lead is a 1OF pacing lead, with 
a pacing tip and two ring electrodes positioned to be within 
the right ventricle. The external pacing system (Fig. 1) 
consists of 1) analog circuitry to sense R waves and pacing 
pulses, generate 2.6 KHz, 10 to 30 PA current signals (for 
impedance measurements) and measure induced intraven- 
tricular voltages (from which impedance measurements were 
calculated); 2) an analog to digital (A/D) converter to trans- 
form real time, analog circuitry measurements into digital 
signals; 3) an Intel computer (model 861330) to provide 
smoothing and filtering of sensed direct current and low 
frequency signals, calculations of impedance and estimates 
of the pre-ejection interval, and 4) a pacing interface module 
. Gqrwate current 2.6 kl-tz 
0 Induced voltage meas’l-m-’ 
0 R-wave dmection 
r A to 0 convert 
..,‘P”‘w”’ H Convert analog signals 
to digital pulses 
a 
( , Intel computer I Pacing intarfew moduls ??Signal smoothing and filtering 
Pacing stimuli 
Convect diem Pulses - ??Calculate impedance 
into pacing stimuli 0 Pacing parameter entries 
1 ??WI and WIR algorithms 
Figure 1. Components of investigational pac- 
ing system (see text). A to D = analog to 
digital; PEI = pre-ejection interval; VVI and 
VVIR = ventricular demand and ventricular 
rate-adaptive pacing, respectively. 
Skin 
electrode 
0 Determine PEI _ 
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to convert the output signals from the computer unit into 
pacing stimuli delivered to the temporary pacing electrodes. 
The pacing stimuli could be produced in a ventricular 
demand (VVI) mode or in a rate-modulated fashion deter- 
mined by changes in measured pre-ejection interval. 
Impedance measurement. The system just described is 
designed to measure the impedance of electrical currents 
injected into the right ventricle to derive information about 
right ventricular volume. The relation of intracavitary vol- 
ume to impedance is based on the observation that for an 
insulated cylinder containing an electrically conductive me- 
dium with a constant homogeneous resistivity: volume = 
resistivity x length’limpedance. As applied to this pace- 
maker system (Fig. I), a subthreshold current of 10 to 30 PA 
is injected from the distal electrode at a frequency of 2.6 
KHz. The voltage is measured across the two proximal 
electrodes that determine the length of the quasi-cylindrical 
right ventricular segment being assessed. Impedance is 
calculated (by Ohm’s law) approximately every 10 ms. 
thereby providing a continuous index of intracavitary right 
ventricular volume. Because the right ventricle is not truly 
cylindrical nor perfectly insulated, volume determinations 
are only approximate, but provide useful information regard- 
ing mechanical ventricular function, including beat to beat 
changes in “stroke volume,” the rate of volume change 
during contraction and the interval between electrical and 
mechanical systolic events. 
Pre-ejection interval measurement. The pre-ejection in- 
terval is defined as the time from the onset of electrical 
systole until the reliable detection of ventricular ejection. 
The onset of electrical systole is determined from the initi- 
ation of a pacing pulse or the detection of a native QRS 
complex. Ventricular ejection is defined as the point after 
systole where the impedance waveform exceeds a previ- 
ously determined percent of the total impedance variation. 
rather than as the precise onset of mechanical contraction. 
Although this method includes a portion of mechanical 
systole in the pre-ejection interval measurement, it was 
chosen because it greatly simplifies the detection process 
and improves consistency when implemented in a micropro- 
cessor environment. Because this interval includes the true 
left ventricular pre-ejection period plus the early portion of 
the left ventricular ejection time, pre-ejection interval values 
are longer than conventional left ventricular pre-ejection 
period determinations. Pre-ejection intervals and conven- 
tional pre-ejection periods probably change in parallel fash- 
ion during stress, It is possible, however, that exertional 
shortening of the pre-ejection interval may be somewhat 
exaggerated because of a concomitantly steeper increase in 
impedance, which causes the detection point signaling the 
end of the pre-ejection interval to be reached earlier. 
The pre-ejection interval varies with changes in adrener- 
gic input IO rhe heurt (I-51. By measuring beat to beat 
changes in the pre-ejection interval, this pacemaker system 
hypothetically can modulate pacing rate in response to the 
exercise-related change in sympathetic tone. This study was 
designed to test this hypothesis. 
Procedure. Each patient was electrocardiographically 
monitored continuously using a modified chest lead I con- 
figuration. The investigational electrode was inserted into 
the right ventricle by standard subclavian venipuncture 
techniques using fluoroscopic guidance on the side contra- 
lateral to the permanent pacemaker. Once positioned, the 
electrode was attached to a pacing system analyzer to 
determine capture threshold and sensing amplitude. After 
satisfactory pacing variables were established. the electrode 
was connected to the external microcomputer pacing equip- 
ment. The patient’s permanent pacemaker was programmed 
to the ventricular demand mode (VVI) at a rate of 50 
beatsimin for the duration of the procedure, during which 
effective pacing was maintained by the investigational sys- 
tem. 
The following maneuvers were then performed. I) With 
the patient sitting, the ventricle was paced for 1 min intervals 
at 70.90, 110 and 130 beatsimin, and the pre-ejection interval 
was measured at each rate. 
Steps 2 and 3 were performed in a randomly determined 
sequence. A minimal 15 min recovery time was permitted 
between exercise sessions, during which blood pressure 
returned to baseline values. 2) During the VVI paced mode 
at a rate of 70 beatsimin (75 beatsimin for one patient), the 
patient performed upright graded bicycle ergometer (Bio- 
Dyne) exercise. One minute stages at levels of 150, 300,600, 
900 and 1,200 kiloponds were performed to completion of the 
exercise protocol or termination because of symptoms. 
3) During rate-modulated ventricular-paced mode using pre- 
ejection interval sensing, the exercise protocol was re- 
peated. An upper paced rate limit of 130 beatsimin was 
programmed. 
Step 4 was done to determine the response of the pacing 
system to sudden onset, high level exercise of short dura- 
tion. This final exercise protocol was performed after a 1.5 
min rest period. 4) During rate-modulated ventricular pac- 
ing. the patient exercised for 1 min at the highest level that 
had been achieved during graded exercise. 
The electrocardiogram, blood pressure, heart rate and 
pre-ejection interval were monitored throughout each exer- 
cise period and during postexercise recovery. At the conclu- 
sion of the procedure, the temporary electrode was removed 
under fluoroscopic guidance. A chest X-ray film was ob- 
tained 2 h after completion of the procedure. Permanent 
pacemakers were reprogrammed to baseline status. 
Statistics. The likelihood of results occurring by chance 
was assessed using Student’s two-tailed t test for paired 
data. Statistically significant results were considered to be 
those with p < 0.05. Values for pre-ejection interval and 
heart rate at each level of exercise were derived from the last 
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Table 2. Pre-ejection Interval (in ms) Response to Exertion in Five Patients 
Patient 
No. 
1 
2 
3 
4 
5 
Mean 
+ SEM 
Pacing 
Mode 
VVI 
VVIR 
VW 
VVIR 
VW 
VVIR 
VVI 
VVIR 
VVI 
VVIR 
VVI 
VVIR 
Rest Light 
531 497 
525 497 
296 279 
381 371 
403 352 
417 347 
252 214 
321 293 
420 331 
423 347 
380 ? 49 335 + 47 
413 + 33 371 2 34 
Exercise Level 
Medium 
498 
346 
263 
341 
342 
317 
214 
271 
282 
350 
320 ? 49 
326 ? 15 
Heavy 
449 
329 
238 
324 
317 
314 
208 
254 
258 
324 
294 f 43 
308 + 14 
A 3 min 
Rest-Heavy Post-exercise 
-82 483 
-199 398 
-58 295 
-57 304 
-86 422 
- 103 428 
-44 261 
-67 309 
-162 382 
-99 432 
-86 t 20* 369 t 40 
-105 + 25* 374 ? 28 
*Difference between pre-ejection interval at rest and during exercise significant at p < 0.025. A Rest-Heavy = change from rest to heavy exercise; VVI = 
ventricular demand: VVIR = rate-adaptive ventricular pacing determined by pre-ejection interval. 
30 s of that stage, which was the point when these values + 22 and 321 t 19 ms at 70, 90, 110 and 130 beats/min, 
were most stable. respectively (p = NS). 
Results 
No adverse effects or complications were experienced by 
any subject during or after exercise or as a result of repro- 
gramming. 
Effect of incremental ventricular pacing rate on pre- 
ejection interval. A variable response of the measured pre- 
ejection interval occurred in response to ventricular pacing 
at progressively higher rates. In general, the pre-ejection 
interval decreased somewhat or remained unchanged. The 
average pre-ejection intervals were 347 * 41, 371 t 26, 364 
Effect of exertion on pre-ejection interval and heart rate 
during ventricular demand pacing. In all cases, pre-ejection 
interval decreased progressively to its shortest duration at 
peak exercise. Patient 4 developed intact atrioventricular 
conduction during exercise, but exhibited a shallow decrease 
in pre-ejection interval. Data from all patients are summa- 
rized in Table 2. Every patient except Patient 4 was pace- 
maker-dependent throughout exercise and remained at the 
fixed pacing rate (Table 3). 
Effect of exertion on pre-ejection interval and heart rate 
during rate-adaptive pacing. With the pacing system pro- 
grammed to permit rate increases in response to detected 
Table 3. Heart Rate (in beats/min) Response to Exertion in Five Patients 
Patient Pacing 
No. Mode Rest Light 
Exercise Level 
Moderate Heavy 
A 3 min 
Rest-Heavy Post-exercise 
I VVI 70 70 70 70 
VVIR 71 78 130 130 
2 VVI 75 15 15 75 
VVIR 76 84 102 120 
3 VW 70 71 70 70 
VVIR 70 Ill 129 129 
4 VVI 73 87 93 105 
VVIR 70 81 89 104 
5 VW 70 72 71 73 
VVIR 72 96 103 106 
Mean VVI 72 2 1 75 + 3 76 + 4 79 k 7 
? SEM VVIR 72 it 1 9026 110 + 8 118 +6 
*Difference between heart rate at rest and during exercise significant at p < 0.005. Abbreviations as in Table 2. 
0 70 
+59 82 
0 75 
t44 81 
0 70 
t59 70 
i32 72 
+34 77 
+3 71 
t34 70 
726 72 t 1 
46 2 6* 76 + 3 
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Figure 2. Effect of graded upright bicycle exercise on heart rate (top) 
and pre-ejection interval (PEI) (bottom) in the five study patients 
during ventricular demand (VW) and ventricular rate-adaptive 
(VVIR) pacing. 
decreases in the pre-ejection interval, an increase in heart 
rate with exercise was observed in each patient. The peak 
heart rate in this mode was 39 * 11 beatsimin or 54 L 14.6% 
over that observed in the ventricular demand mode at 
comparable workloads (p < 0.025) (Table 3). However, 
changes in pre-ejection interval were similar to those ob- 
served during VVI pacing (Table 2). Figure 2 illustrates the 
obvious rate responsiveness of the pacing system, and 
shows that the pre-ejection interval is similar at similar work 
loads despite the differences in heart rate during the two 
pacing modes. 
Sudden relativrly strenuous exertion produced a very 
rapid decrease in the pre-ejection interval and a concomitant 
increase in pacing rate, usually to the upper rate level (Fig. 
3). This was followed by a relatively rapid return to baseline 
values after cessation of exercise, similar to that observed 
after graded exercise (Tables 2 and 3). 
Discussion 
Pre-ejection interval as rate modulator. The purpose of 
this study was to determine whether the pre-ejection interval 
could serve as a reflection of global metabolic demand and, 
thus, as a determinant of pacing rate. Our results indicate 
PEI 
c 300 EXWClSe 
g 200 Level 
I I I I I , I ] 
1 2 3 4 5 6 7 8 9 10 
Minutes 
Figure 3. Effect of sudden onset, short duration (I min). strenuous 
exertion in typical patient. PEI = pre-ejection interval. 
that pre-ejection interval sensing meets the main prerequi- 
sites of a rate-modulating pacing system: the sensed variable 
(pre-ejection interval) 1) varies with degree of exertion, 2) 
responds rapidly after the onset of exertion, 3) can be used in 
an algorithm that increases pacing stimulus frequency with 
exertion and permits return to baseline rates appropriately 
after termination of exercise, and 4) is not significantly 
affected by heart rate changes (thereby avoiding a positive 
feedback phenomenon). By utilizing a pre-ejection interval 
sensing system, the pacing rate could be increased in a quali- 
tatively physiologic manner in all pacemaker-dependent 
patients. 
Whether the rate-modulating pacing mode is capable of 
improving exercise tolerance or reducing symptoms related 
to fixed rate pacing was not evaluated in the present study. 
Previous studies (7-8) of other rate-modulating pacing sys- 
tems or models suggest that such benefit does occur. Also, 
no comparison was attempted between patients with and 
without appropriate sinus node function. 
Advantages of pre-ejection interval sensing system. One 
potential specific advantage of a pre-ejection interval sensing 
system is that it responds to alterations in a variable that 
reflects the net neurohumoral regulatory input to the heart, 
regardless of specific cause. In effect, the pre-ejection inter- 
val represents a common denominator of adrenergic stimu- 
lation caused by any metabolic demand, whether it is elicited 
by isometric or dynamic activity, a febrile state, emotional 
stress or medication. Thus, not only should it respond to a 
broad number of stimuli that normally influence heart rate, 
but also it is perhaps less likely to be artifactually influenced 
by signals mimicking physiologic stimuli. A further advan- 
tage of a pre-ejection interval sensing system is its utilization 
of a volume-sensing electrode catheter that is capable of 
sensing other physiologic indexes such as relative stroke 
volume and rate of change of volume during ventricular 
contraction and relaxation. This may permit additional or 
alternative determinants of pacing rate, as well as useful 
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information (by telemetry) regarding cardiac output and the 
contractile status of the myocardium. 
Potential disadvantages. As with most rate-modulated 
pacing systems, potential disadvantages may occur. Physio- 
logic rate responsiveness in chronically bradyarrhythmic 
patients may induce symptoms, particularly if underlying 
ischemic heart disease is present. Relatively higher paced 
heart rates have a small likelihood of enhancing tachyar- 
rhythmias in some patients with reentrant arrhythmias. 
Potential disadvantages unique to this pacing system, if any, 
await clinical trials of an implantable device; no specific 
adverse outcomes were noted in this study. At present, the 
requirement for a tripolar electrode would not permit an 
implantable pacemaker of this type to be used with a 
previously inserted conventional electrode. 
Implications. This study provides the impetus for the 
development and clinical testing of an implantable pacing 
system incorporating pre-ejection interval sensing as a de- 
terminant of physiologic pacing rates. It also suggests that 
such a system will be capable of providing patients with all 
the advantages of rate modulation, as well as additional 
theoretical benefits. 
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